Posted: 04 Jul 2011 12:16 AM PDT Anti-psychotic medications comprise between 30–50% of all psychotropics prescribed for people with learning disabilities as reported in this WELD post: This study set out to explore metabolic syndrome (a group of risk factors that occur together and increase the risk for coronary artery disease, stroke and type 2 diabetes in people with learning disabilities who [...] |
9 Jul 2011
Poor monitoring for metabolic syndrome in people with learning disability taking antipsychotic medication
